bell
The current prices are delayed by 15 mins, login to check live prices.
Ind-Swift Laboratories Ltd share price logo

Ind-Swift Laboratories Ltd

(INDSWFTLAB)

₹113.281.61%

as on 04:01PM, 11 Oct 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Ind-Swift Laboratories Ltd Performance

  • Day's Low

    Day's High

    ₹112.7
    ₹117.6
  • 52 Week's Low

    52 Week's High

    ₹81.85
    ₹186
1 Month Return-21.55 %
3 Month Return-15.79 %
1 Year Return+ 23.74 %
Previous Close₹115.13
Open₹117.60
Volume57.16K
Upper Circuit-
Lower Circuit-
Market Cap₹680.27Cr

Ind-Swift Laboratories Ltd Key Statistics

P/E Ratio1.65
PEG Ratio0.03
Market Cap₹680.27 Cr
P/B Ratio0.63
EPS71.33
Dividend Yield0
SectorPharmaceuticals
ROE18.99

Ind-Swift Laboratories Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹680.27 Cr38.17%0.51₹421 Cr₹1,280 Cr
NA₹173.35 Cr-0.77%0.96NANA
NA₹3,935.89 Cr90.73%0.70₹86 Cr₹806 Cr
NA₹44.65 Cr-16.39%0.50NANA
NA₹812.76 Cr63.3%0.52NANA

About Ind-Swift Laboratories Ltd

IndSwift Laboratories Ltd is an Indian based company that manufactures and sell Active Pharmaceutical Ingredients (API). Established in 1995, the company has grown to encompass 25 products, the most significant being Clarithromycin Macrolide antibiotic, Atorvastatin anticholestrol, Fexofenadine antihistamine, Clopidogrel anticholestrol, Nitazoxanide antidiarrheal, Pioglitazone antidiabetic, Letrozole and Anastrozole anticancer, Venlafaxine antidepressants, and Quetipine and Aripirazole antipsychotic. IndSwift Laboratories Ltd has built a strong presence in 40 plus countries, have a subsidiary in the USA, and set up a state of the art R&D Centre with a USD 5 million investment. Additionally, the production capacity has been increased to 418.18 TPA and its product portfolio continues to expand with compounds like Dutasteride, Cinacalcet, Duloxetine, Mecloxamine citrate, Atomoxetine, Exemestane, and more. In order to explore new opportunities in pharma, the company has entered joint ventures with Wellgen Medicare LLP and Mr. Anshul Jain, and Mr. Ramesh Mehta. As of now, the company has 3 subsidiaries - IndSwift Laboratories Inc in the US, Fortune India Constructions Limited in India, and Halcyon Life Sciences Pvt Ltd in India.

Share Price: ₹113.28 per share as on 11 Oct, 2024 04:01 PM
Market Capitalisation: ₹680.27Cr as of today
Revenue: ₹33.17Cr as on June 2024 (Q2 24)
Net Profit: ₹1.01Cr as on June 2024 (Q2 24)
Listing date: 01 Nov, 2001
Chairperson Name: N R Munjal
OrganisationInd-Swift Laboratories Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Ind-Swift Laboratories Ltd

  • Ind-Swift Laboratories Ltd Share Price Surges by 29% - 02 Jul, 2024

    The share price of Ind-Swift Laboratories Limited has surged higher by 29% over the last month, bringing the annual gain to a sharp 51%. The company's lower P/S ratio may indicate potential risks placing downward pressure on the share price.

  • Ind-Swift Laboratories Ltd Stock Up 296% in Five Years - 29 Jun, 2024

    Ind-Swift Laboratories' stock has grown by 32% CAGR over five years, with a 30% increase in the last quarter. The company moved from loss to profitability during this period.

  • Ind-Swift Laboratories to Raise Funds Through Issuance of Instruments - 25 Jun, 2024

    Ind-Swift Laboratories reported a consolidated net profit of Rs 238.82 crore in Q4 FY24, compared to a net loss of Rs 25.12 crore in Q4 FY23. The company's board will meet on June 27, 2024, to raise funds through the issuance of one or more instruments via various modes.

Insights on Ind-Swift Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 55.80% to 56.21% in Aug 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 85.9% return, outperforming this stock by 62.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 42.00% of holdings in Aug 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 129.2% return, outperforming this stock by 51.7%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.26% to 0.85% in Aug 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 805.18 Cr → 44.31 Cr (in ₹), with an average decrease of 94.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, INDSWFTLAB stock has moved down by -6.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 352.64 Cr → 0.94 Cr (in ₹), with an average decrease of 99.7% per quarter

Ind-Swift Laboratories Ltd Financials

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹310.34Cr (-)₹289.71Cr (↓6.65%)₹287.51Cr (↓0.76%)₹393.33Cr (↑36.81%)₹33.17Cr (↓91.57%)
Net Income₹17.40Cr (-)₹31.83Cr (↑82.93%)₹19.53Cr (↓38.64%)₹352.69Cr (↑1,705.89%)₹1.01Cr (↓99.71%)
Net Profit Margin5.61% (-)10.99% (↑95.90%)6.79% (↓38.22%)89.67% (↑1,220.62%)3.04% (↓96.61%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,817.20Cr (-)₹1,802.92Cr (↓0.79%)₹1,788.27Cr (↓0.81%)₹1,104.77Cr (↓38.22%)
Total Liabilities₹1,178.50Cr (-)₹1,170.36Cr (↓0.69%)₹1,112.92Cr (↓4.91%)₹182.52Cr (↓83.60%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹123.16Cr (-)₹135.03Cr (↑9.64%)₹136.26Cr (↑0.91%)₹182.67Cr (↑34.06%)-₹179.77Cr (↓198.41%)
0

Ind-Swift Laboratories Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
42%
0.00
Foreign Institutions
0.85%
-32.96
Mutual Funds
0%
0.00
Retail Investors
56.21%
0.75
Others
0.94%
0.00

Ind-Swift Laboratories Ltd Key Indicators

Details20202021202220232024
Earning Per Share (₹)-3.54-0.53-0.36871.33
Details20232024
Return On Equity %11.5718.99
Details20202021202220232024
Return On Assets %-1.09-0.17-0.122.6638.1
Details20202021202220232024
Book Value Per Share (₹)69.4965.6767.6383.36157.64

Ind-Swift Laboratories Ltd Valuation

Ind-Swift Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-1795.00x)

December 8, 2022

Today (1.65x)

October 11, 2024

Industry (58.02x)

October 11, 2024

Highest (64.97x)

July 19, 2021

LowHigh

Ind-Swift Laboratories Ltd Earnings and Dividends

  • Ind-Swift Laboratories Ltd Earnings Results

    Ind-Swift Laboratories Ltd’s net profit fell -94.55% since last year same period to ₹0.94Cr in the Q1 2024-2025. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated -99.73% fall in its net profits since last 3-months.

    Read More about Earnings Results

Ind-Swift Laboratories Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Ind-Swift Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Ind-Swift Laboratories Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Ind-Swift Laboratories Ltd shares.

Ind-Swift Laboratories Ltd (INDSWFTLAB) share price today is ₹113.28

Ind-Swift Laboratories Ltd is listed on NSE

Ind-Swift Laboratories Ltd is listed on BSE

  • Today’s highest price of Ind-Swift Laboratories Ltd is ₹117.6.
  • Today’s lowest price of Ind-Swift Laboratories Ltd is ₹112.7.

PE Ratio of Ind-Swift Laboratories Ltd is 1.65

PE ratio = Ind-Swift Laboratories Ltd Market price per share / Ind-Swift Laboratories Ltd Earnings per share

Today’s traded volume of Ind-Swift Laboratories Ltd(INDSWFTLAB) is 57.16K.

Today’s market capitalisation of Ind-Swift Laboratories Ltd(INDSWFTLAB) is ₹680.27Cr.

Ind-Swift Laboratories Ltd(INDSWFTLABPrice
52 Week High
₹186
52 Week Low
₹81.85

Ind-Swift Laboratories Ltd(INDSWFTLAB) share price is ₹113.28. It is down -39.10% from its 52 Week High price of ₹186

Ind-Swift Laboratories Ltd(INDSWFTLAB) share price is ₹113.28. It is up 38.40% from its 52 Week Low price of ₹81.85

Ind-Swift Laboratories Ltd(INDSWFTLABReturns
1 Day Returns
-1.85%
1 Month Returns
-21.55%
3 Month Returns
-15.79%
1 Year Returns
23.74%